Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

0 source entries across 0 studies. This list may not include all unresolved or historical entries.

    Success Metrics

    Active Trials
    1(50%)

    Phase Distribution

    Not Applicable
    1
    50%
    Phase 2/3
    1
    50%

    Phase Distribution

    0

    Early Stage

    1

    Mid Stage

    0

    Late Stage

    Phase Distribution2 total trials
    Phase 2/3Combined phases
    1(50.0%)
    N/ANon-phased studies
    1(50.0%)

    Highest Phase Reached

    Phase 2/3

    Trial Status & Enrollment

    Completion Rate

    0.0%

    0 of 0 finished

    Non-Completion Rate

    0.0%

    0 ended early

    Currently Active

    1

    trials recruiting

    Total Trials

    2

    all time

    Status Distribution
    Active(1)
    Other(1)

    Detailed Status

    Recruiting1
    unknown1

    Development Timeline

    Analytics

    Development Status

    Total Trials
    2
    Active
    1
    Success Rate
    N/A
    Most Advanced
    Phase 2/3

    Trials by Phase

    Phase 2/31 (50.0%)
    N/A1 (50.0%)

    Trials by Status

    recruiting150%
    unknown150%

    Recent Activity

    1 active trials
    Showing 2 of 2
    recruitingphase_2_3

    Prevention of Hernia After Loop Ileostomy Reversal

    NCT03720262
    unknownnot_applicable

    ReAL Trial (Rectal Anastomotic seaL)

    NCT03941938

    Clinical Trials (2)

    Showing 2 of 2 trials
    NCT03720262Phase 2/3

    Prevention of Hernia After Loop Ileostomy Reversal

    Recruiting
    NCT03941938Not Applicable

    ReAL Trial (Rectal Anastomotic seaL)

    Unknown

    All 2 trials loaded

    Drug Details

    Intervention Type
    Varies by study
    Total Trials
    2